Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.

Journal of comparative effectiveness research·2026

Same author

In Vivo Base Editing of <i>PCSK9</i> with VERVE-102 for Hypercholesterolemia.

The New England journal of medicine·2026

Same author

Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.

European journal of preventive cardiology·2026

Same author

Interrelationship Between Socioeconomic Status, Depression, and Neuropathy in People with Diabetes: A Cross-Sectional Study.

Journal of clinical medicine·2026

Same author

Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review.

European journal of internal medicine·2025

Same author

Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United Kingdom.

Genetics in medicine open·2025

Same journal

Real-World Performance of the MiniMed 780G Advanced Hybrid Closed Loop Automated Insulin Delivery System in Greece.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026

Same journal

Real-World Glucometric Outcomes of the MiniMed 780G Advanced Hybrid Closed-Loop System in Users with Type 1 Diabetes in Spain.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026

Same journal

Basal Insulin Adherence in Patients with Type 2 Diabetes Mellitus in Routine Clinical Practice in Spain: Clinical and Economic Impact.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026

Same journal

Novel Clinical and Pre-clinical Obesity Estimates in Older Indian Adults: Insights from a Nationally Representative Dataset.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026

Same journal

Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026

Same journal

Overlap of Gestational Diabetes Mellitus and Pre-eclampsia: A Scoping Review.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 22, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

Diabetes Dyslipidemia.

Jonathan D Schofield^1,2, Yifen Liu³, Prasanna Rao-Balakrishna⁴

¹Faculty of Medical and Human Sciences, Institute of Human Development, University of Manchester, Manchester, UK. jschofield@doctors.org.uk.

Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders

|April 9, 2016

Summary

This summary is machine-generated.

Diabetes increases cardiovascular disease risk, but intensive glucose control shows limited benefit. Cholesterol lowering is crucial for managing dyslipidemia in diabetic patients, improving cardiovascular outcomes.

Keywords:

Cardiovascular risk Diabetes Dyslipidemia Lipoproteins Low density lipoprotein cholesterol

More Related Videos

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

Related Experiment Videos

Last Updated: Mar 22, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

Area of Science:

Cardiology
Endocrinology
Metabolic Diseases

Background:

Diabetes mellitus significantly elevates the risk of premature atherosclerotic cardiovascular disease.
Intensive glycemic control trials have yielded limited success in improving cardiovascular outcomes.
Dyslipidemia is prevalent in diabetes and lipid-lowering therapies demonstrably improve cardiovascular health.

Purpose of the Study:

To review the pathophysiology and implications of lipoprotein alterations in type 1 and type 2 diabetes.
To examine the impact of common diabetes medications on lipid profiles.
To synthesize evidence on lifestyle and pharmaceutical interventions for managing dyslipidemia in diabetic individuals.

Main Methods:

Literature review of studies on diabetes, dyslipidemia, and cardiovascular disease.
Analysis of clinical trial data regarding glycemic control and cardiovascular outcomes.
Examination of lipid profile changes associated with diabetes medications and interventions.

Main Results:

Diabetes is linked to specific lipoprotein abnormalities contributing to cardiovascular risk.
Cholesterol-lowering interventions show significant cardiovascular benefits in diabetic populations.
Current evidence supports lifestyle modifications and pharmaceutical treatments for diabetic dyslipidemia.

Conclusions:

Effective management of dyslipidemia is essential for reducing cardiovascular events in diabetes.
Comprehensive strategies integrating lifestyle, medication, and lipid management are recommended.
Guidelines for managing dyslipidemia in diabetes require ongoing updates based on emerging evidence.